Acumen Pharmaceuticals Reports Financial Results for Second Quarter 2022 and Business Highlights

Go back to Acumen Pharmaceuticals Reports Financial Results for Second Quarter 2022 and Business Highlights

Acumen Pharmaceuticals, Inc. (ABOS) Reports In-Line Q2 EPS

August 15, 2022 4:13 PM EDT

Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS) reported Q2 EPS of ($0.25), in-line with the analyst estimate of ($0.25).

For earnings history and earnings-related data on Acumen Pharmaceuticals, Inc. (ABOS) click here.

... More